Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 03/2/15 → 09/26/19 |
Funding
- National Cancer Institute: $1.00
Randomized Double Blind Placebo Controlled Study of Erlotinib or Placebo in Patients with Completely Resected Epidermal Growth Factor Receptor (EGFR) Mutant Non-Small Cell Lung Cancer (NSCLC)
- Keresztes, Roger (PI)
- Zhang, Yue (CoPI)
Project: Research